Attachment A1 - FRN 60-Day Publication

55579

Federal Register / Vol. 84, No. 201 / Thursday, October 17, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request; Information
Collection Request Title: Evaluation of
the Maternal and Child Health Bureau
Pediatric Mental Health Care Access
(PMHCA) Program and the Maternal
and Child Health Bureau Screening
and Treatment for Maternal Depression
and Related Behavioral Disorders
Program, OMB No. 0906–xxxx, New
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:

In compliance with the
requirement of the Paperwork
Reduction Act of 1995 for opportunity
for public comment on proposed data
collection projects, HRSA announces
plans to submit an Information
Collection Request (ICR), described
below, to the Office of Management and
Budget (OMB). Prior to submitting the
ICR to OMB, HRSA seeks comments
from the public regarding the burden
estimate, below, or any other aspect of
the ICR.
DATES: Comments on this ICR should be
received no later than December 16,
2019.
ADDRESSES: Submit your comments to
[email protected] or mail the HRSA
Information Collection Clearance
Officer, Room 14N136B, 5600 Fishers
Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email [email protected]
or call Lisa Wright-Solomon, the HRSA
Information Collection Clearance Officer
at (301) 443–1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference.
Information Collection Request Title:
Evaluation of Maternal and Child Health
SUMMARY:

Bureau Pediatric Mental Health Care
Access Program and the Maternal and
Child Health Bureau Screening and
Treatment for Maternal Depression and
Related Behavioral Disorders Program,
OMB No. 0906–xxxx—New.
Abstract: HRSA’s Maternal and Child
Health Bureau Pediatric Mental Health
Care Access (PMHCA) and Maternal
Depression and Related Behavioral
Disorders (MDRBD) programs aim to
increase identification of behavioral
health conditions by screening specified
populations (e.g., children, adolescents,
young adults, and pregnant and
postpartum women, especially those
living in rural, isolated, and
underserved areas); providing clinical
behavioral health consultation; care
coordination support (e.g.,
communication/collaboration, accessing
resources, referral services) and training
to health care providers; and increasing
access to clinical interventions
including by telehealth. Provider
education and training will support the
knowledge and skills acquisition
needed to accomplish this goal. PMHCA
program is authorized by the Public
Health Service Act, § 330M (42 U.S.C.
254c–19), as amended. The MDRBD
program is authorized by the Public
Health Service Act, § 317L–1 (42 U.S.C.
247b–13a), as amended. In order to
evaluate progress made toward the
programs’ goals, this data collection will
use four instruments: Health Care
Provider (HCP) Survey, Practice-Level
Survey, Program Implementation
Survey, and Program Implementation
Semi-Structured Interview.
Need and Proposed Use of the
Information: This information is needed
to evaluate the PMHCA and MDRBD
Programs by providing HRSA with the
necessary information to guide future
policy decisions regarding increasing
health care providers capacity to
address patient’s behavioral health and
access to behavioral health services.
Specifically, data collected for the
evaluation will be used to study the
efforts of awardee programs to achieve
key awardee outcomes (e.g., increase in
access to behavioral health services;
providers trained; available communitybased resources, including counselors or
family service providers) and to

measure whether and to what extent
awardee programs are associated with
changes in these key awardee outcomes.
The evaluation will also examine
changes over time, within a state and/
or across the PMCHA and MDRBD
programs, with regard to (1) enrolled
providers/practices related to screening,
referral, and care coordination for
behavioral health conditions; (2)
provision of behavioral health services
for mental health conditions in primary
care settings by enrolled health care
providers; (3) use of consultative
services; and (4) facilitation of access to
behavioral health services for mental
health conditions.
Likely Respondents: Both HCP and
Practice-Level Survey responses will be
collected from health care providers and
practices that are participating in the
PMCHA and MDRBD programs. Likely
respondents include:
• HCP Surveys: Physicians, nurse
practitioners, physician assistants,
nurse midwives (for MDBRD), other
health care professionals (e.g.,
behavioral health providers, case
coordinators, nurses, social workers)
• Practice-Level Surveys: Practice
managers (e.g., office managers, office
leadership, nurse champions)
• Program Implementation Surveys and
Semi-Structured Interviews: PMHCA
and MDRBD cooperative agreementfunded Project Directors/Principal
Investigators
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Form name

Health Care Provider Survey ...............................................
Practice-Level Survey ..........................................................
Program Implementation Survey .........................................

VerDate Sep<11>2014

17:26 Oct 16, 2019

Jkt 250001

PO 00000

Frm 00040

Number of
responses per
respondent

13,035
4,165
28

Fmt 4703

Sfmt 4703

3
3
3

Total
responses
39,105
12,495
84

E:\FR\FM\17OCN1.SGM

17OCN1

Average
burden per
response
(in hours)
0.17
0.25
0.50

Tota
burden
hours
6,648
3,124
42

55580

Federal Register / Vol. 84, No. 201 / Thursday, October 17, 2019 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents

Form name

Number of
responses per
respondent

Total
responses

Average
burden per
response
(in hours)

Tota
burden
hours

Program Implementation Semi-Structured Interview ...........

28

1

28

1.00

28

Total ..............................................................................

17,256

........................

51,712

........................

9,842

HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.

Contact Person: Jing Chen, Ph.D., Scientific
Review Officer, Office of Scientific Review,
National Center for Advancing Translational
Sciences (NCATS), National Institutes of
Health, 6701 Democracy Blvd., Democracy 1,
Room 1080, Bethesda, MD 20892–4874,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: October 10, 2019.

[FR Doc. 2019–22636 Filed 10–16–19; 8:45 am]

Melanie J. Pantoja,

BILLING CODE 4165–15–P

Program Analyst, Office of Federal Advisory
Committee Policy.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2019–22572 Filed 10–16–19; 8:45 am]
BILLING CODE 4140–01–P

National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Center for Advancing
Translational Sciences; Notice of
Closed Meeting

National Institutes of Health

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Platform Delivery
Technologies for Nucleic Acid Therapeutics.
Date: November 13–14, 2019.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).

VerDate Sep<11>2014

17:26 Oct 16, 2019

Jkt 250001

Office of the Director, National
Institutes of Health; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the Office of AIDS
Research Advisory Council, November
7, 2019 from 8:30 a.m. to 4:30 p.m.,
National Institutes of Health, 5601
Fishers Lane, Room 1D13, Rockville,
MD 20852 which was published in the
Federal Register on February 15, 2019,
84 FR 4495.
This meeting notice is amended to
change the meeting date from November
7, 2019 to October 28, 2019 at the
National Institutes of Health, 5601
Fishers Lane, Room 1D13, Rockville,
MD 20852. The meeting is open to the
public.
Dated: October 10, 2019.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Genetic
Epidemiology and Secondary Data Analysis
Applications.
Date: November 4–5, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Eye Institute, National
Institutes of Health, 6700 B Rockledge Drive,
Suite 3400, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Brian Hoshaw, Ph.D.,
Acting Review Chief, National Eye Institute,
National Institutes of Health, Division of
Extramural Research, 6700 B Rockledge
Drive, Suite 3400, Rockville, MD 20892, (301)
451–2020, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: October 10, 2019.
Miguelina Perez,

Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–22571 Filed 10–16–19; 8:45 am]

Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–22573 Filed 10–16–19; 8:45 am]
BILLING CODE 4140–01–P

BILLING CODE 4140–01–P

PO 00000

Frm 00041

Fmt 4703

Sfmt 4703

E:\FR\FM\17OCN1.SGM

17OCN1